Table 4 Medication data
From: Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study
| Â | Remission group | AU group | Pre- and post-treatment | |||
|---|---|---|---|---|---|---|
cases | doses (mg/day) | cases | doses (mg/day) | cases | doses (mg/day) | |
Antipsychotics | ||||||
 Perphenazine | 3 | 17.33 ± 8.33 | 5 | 17.60 ± 11.52 | 6 | 19.33 ± 10.86 |
 Sulpiride | – | – | 1 | 600.00 | – | – |
 Risperidone | 45 | 5.36 ± 1.32 | 26 | 4.52 ± 1.89 | 53 | 4.86 ± 1.55 |
 Amisulpride | 7 | 885.71 ± 302.37 | 9 | 600.00 ± 300.00 | 14 | 650 ± 295.48 |
 Olanzapine | 10 | 13.50 ± 2.42 | 16 | 14.38 ± 8.39 | 18 | 14.44 ± 4.50 |
 Ziprasidone | 2 | 140 ± 28.28 | 4 | 80 ± 46.19 | 2 | 100 ± 84.85 |
 Quetiapine | 7 | 285.71 ± 89.97 | 9 | 327.78 ± 207.83 | 14 | 296.43 ± 171.49 |
 Clozapine | 13 | 153.85 ± 96.74 | 12 | 176.04 ± 162.23 | 10 | 111.25 ± 110.62 |
 Aripiprazole | 16 | 15.31 ± 9.74 | 22 | 17.05 ± 7.82 | 22 | 18.09 ± 10.08 |
Mood stabilizers | ||||||
 Valproate | 3 | 700.00 ± 255.84 | 2 | 700.00 ± 278.65 | 5 | 675.56 ± 245.09 |
 Lithium | 2 | 425.00 ± 206.16 | 1 | 560.00 ± 251.00 | 3 | 478.57 ± 191.17 |
 Lamotrigine | – | – | 1 | 37.50 | – | – |
Antidepressants | ||||||
 Escitalopram | 3 | 10.00 ± 5.00 | – | – | 4 | 10 ± 4.08 |
 Fluvoxamine | – | – | 1 | 75 | – | – |
 Sertraline | 2 | 50.00 | 5 | 60.00 ± 22.36 | 3 | 50.00 |
 Paroxetine | 2 | 40.00 | – | – | 1 | 20.00 |
 Trazodone | 1 | 50.00 | – | – | – | – |